Domača stranP8A • SGX
add
Cordlife Group Ltd
Prejšnji trg. dan.
0,16 $
Letni razpon
0,12 $ - 0,46 $
Tržna kapitalizacija
41,47 mio. SGD
Povprečni obseg
24,84 tis.
Razm. P/E
-
Dividendna donosnost
-
Primarna borza
SGX
Borzne novice
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (SGD) | jun. 2024info | Sprememba L/L |
|---|---|---|
Prihodek | 4,60 mio. | −67,54 % |
Stroški poslovanja | 8,59 mio. | −6,80 % |
Čisti dohodek | −6,18 mio. | −655,33 % |
Čista dobičkovnost prihodkov | −134,45 | −1.810,56 % |
Earnings per share | — | — |
EBITDA | −6,84 mio. | −615,37 % |
Efektivna davčna stopnja | 8,73 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (SGD) | jun. 2024info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 59,54 mio. | −15,89 % |
Skupna sredstva | 224,31 mio. | −4,16 % |
Skupne obveznosti | 101,27 mio. | 3,31 % |
Celoten lastniški kapital | 123,03 mio. | — |
Shares outstanding | 256,31 mio. | — |
Razmerje P/B | 0,32 | — |
Donosnost sredstev | −8,79 % | — |
Donosnost kapitala | −15,66 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (SGD) | jun. 2024info | Sprememba L/L |
|---|---|---|
Čisti dohodek | −6,18 mio. | −655,33 % |
Denar iz dejavnosti | −2,95 mio. | −192,71 % |
Denar iz naložb | 2,90 mio. | 258,76 % |
Denar iz financiranja | −549,50 tis. | −19,59 % |
Neto sprememba denarnih sredstev | −498,00 tis. | −153,06 % |
Prost denarni tok | −4,65 mio. | −1.473,26 % |
Vizitka
Incorporated in May 2001, Cordlife Group Limited, is a consumer health company and one of the leading providers of cord blood and cord lining banking services in Asia. Cordlife has been listed on the mainboard of SGX since March 2012.
The Group owns the largest network of cord blood banks in Asia with full stem cell processing and storage facilities in six key markets namely Singapore, Hong Kong, India, Indonesia and the Philippines. Beyond cord blood and cord lining banking, Cordlife offers a comprehensive suite of diagnostics services, particularly for the mother and child segment, including urine-based newborn metabolic screening, non-invasive prenatal testing, paediatric vision screening and family genetic screening services.
In January 2018, Cordlife acquired HealthBaby Biotech Co., Limited, the largest private cord blood bank in Hong Kong. Through its majority-owned subsidiary, Stemlife Berhad in Malaysia, Cordlife controls an indirect stake in Thailand's largest private cord blood bank, Thai Stemlife. Cordlife is also the first Singapore private cord blood bank to provide cord blood and cord lining banking services in Myanmar and Vietnam. Wikipedia
Generalni direktor
Datum ustanovitve
2. maj 2001
Spletno mesto
Zaposleni
111
